No Data
No Data
Clearmind Medicine Completes the Initiation of Its Alcohol Use Disorder Phase I/IIa Clinical Trial at All Current Clinical Sites
Express News | Reported Earlier: 'Texas Lawmakers Take Up Bills To Expedite Access To Psychedelic Therapy' - Marijuana Moment
Clearmind Medicine to Host Live Webinar "Gazing Through the Crystal Ball" Featuring Leading Psychedelic Experts
Clearmind Medicine Receives Notice of Allowance for United States Patent Covering Binge Behavior
Express News | Clearmind Medicine Shares Are Trading Higher After the Company Announced the Launch of Its First US Clinical Site for Its Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder
Clearmind Medicine Initiates Phase I/IIa Clinical Trial At Its First U.S. Clinical Site, Johns Hopkins University School Of Medicine